Correction: Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohort

Correction: Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohort

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-10-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/8/2/e000664corr1.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies
by: Renee N Donahue, et al.
Published: (2020-10-01)

Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer
by: Makoto Ueno, et al.
Published: (2020-05-01)

Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer
by: Arun Rajan, et al.
Published: (2024-03-01)

PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancer
by: Charalampos S. Floudas, et al.
Published: (2025-03-01)

Role of E-cadherin and β-catenin in head and neck squamous cell carcinoma
by: A. A. Petrova, et al.
Published: (2024-01-01)

Molecular features of head and neck squamous cell carcinoma
by: G. V. Kakurina, et al.
Published: (2018-09-01)

Clinicopathological profile of head and neck squamous cell carcinoma
by: Senjuti Dasgupta, et al.
Published: (2019-01-01)

Multimodal fusion model for prognostic prediction and radiotherapy response assessment in head and neck squamous cell carcinoma
by: Ruxian Tian, et al.
Published: (2025-05-01)

Predicting response to PD-1 inhibitors in head and neck squamous cell carcinomas using peripheral blood inflammatory markers
by: Ruihua Fang, et al.
Published: (2025-01-01)

Prospects of epigenetic therapy of head and neck squamous cell carcinoma
by: R. N. Mustafin
Published: (2023-09-01)

MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas
by: Muzaffar Shah-Khan, et al.
Published: (2013-03-01)

Risk Factors and Diagnosis of Head and Neck Squamous Cell Carcinoma
by: Yussy Afriani Dewi, et al.
Published: (2024-12-01)

EXPRESSION PROFILE OF MICRORNAS IN SQUAMOUS CELL HEAD AND NECK CARCINOMA
by: Yu. A. Veryaskina, et al.
Published: (2016-02-01)

SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK: NEW AVENUES OF TREATMENT?
by: T. Braunschweig, et al.
Published: (2015-04-01)

TGFβ-signaling in Squamous Cell Carcinoma Occurring in Recessive Dystrophic Epidermolysis Bullosa
by: Julia Knaup, et al.
Published: (2011-01-01)

Causal role of immune cells in head and neck squamous cell carcinoma
by: Panshu Xu, et al.
Published: (2025-03-01)

Contrast-enhanced ultrasound in the diagnosis of head and neck squamous cell carcinoma
by: G. F. Allakhverdieva, et al.
Published: (2019-04-01)

Methylation of the tumor associated genes in head and neck squamous cell carcinoma
by: S. V. Kurevlev, et al.
Published: (2023-03-01)

Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma
by: Aidan G. Major, et al.
Published: (2013-01-01)

Immunosuppression and Outcomes in Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck
by: Doriana Iancu, et al.
Published: (2025-01-01)

Prosaposin – A plausible biomarker in head and neck squamous cell carcinoma
by: Avradeep Datta, et al.
Published: (2024-03-01)

No Evidence for FANCF Gene Silencing in Head-and-Neck Squamous Cell Carcinomas
by: Najim Ameziane, et al.
Published: (2009-01-01)

Editorial: Overcoming therapeutic resistance in head and neck squamous cell carcinoma
by: Souvick Roy, et al.
Published: (2025-06-01)

Recent advances of photodiagnosis and treatment for head and neck squamous cell carcinoma
by: Yining Zhang, et al.
Published: (2025-02-01)

Epithelial-Mesenchymal Transition and Inflammation in Head and Neck Squamous Cell Carcinoma
by: Habib Sadeghi Rad, et al.
Published: (2020-04-01)

Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma
by: Lucie Heinzerling, et al.
Published: (2025-02-01)

Expression and clinical significance of IGFBP7 and TGFβ1 in esophageal squamous cell carcinoma
by: REN Huaijing, MA Zhenqi WANG, Xuehong TAO Jianan
Published: (2025-01-01)

Expression analysis of transforming growth factor beta (TGF-β) in oral squamous cell carcinoma
by: Arun Ganesh, et al.
Published: (2024-03-01)

Blocking YAP1–Liprin-β2 interaction impedes metastasis and promotes tumor suppression in head and neck squamous carcinoma
by: Seon Rang Woo, et al.
Published: (2025-07-01)

SPP1+ macrophages promote head and neck squamous cell carcinoma progression by secreting TNF-α and IL-1β
by: Chun Liu, et al.
Published: (2024-12-01)

Durable response to nivolumab in combination with regional hyperthermia in a patient with PD-L1-negative metastatic head and neck squamous cell carcinoma
by: Luc M. Berclaz, et al.
Published: (2025-04-01)

Mature tertiary lymphoid structures linked to HPV status and anti-PD-1 based chemoimmunotherapy response in head and neck squamous cell carcinoma
by: Lizao Zhang, et al.
Published: (2025-12-01)

VPS25 Promotes an Immunosuppressive Microenvironment in Head and Neck Squamous Cell Carcinoma
by: Li-Guo Chen, et al.
Published: (2025-02-01)

Study of head and neck squamous cell carcinoma transcriptome after proton therapy
by: E. D. Jumaniyazova, et al.
Published: (2024-04-01)

Current trends in the immunotherapy of metastatic and recurrent squamous cell carcinoma of the head and neck
by: Yu. V. Kostalanova, et al.
Published: (2020-11-01)

THE ROLE OF PSMA PET/CT IN THE CHARACTERIZATION OF HEAD AND NECK SQUAMOUS CELL CARCINOMA
by: Hadila da Silva Veras Sousa, et al.
Published: (2025-05-01)

FAP Serves as a Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma
by: Zhanpeng Liao, et al.
Published: (2024-01-01)

ASSESSMENT OF BLOOD SERUM PROTEOME IN PATIENTS WITH SQUAMOUS CELL HEAD AND NECK CARCINOMA
by: G. V. Kakurina, et al.
Published: (2016-02-01)

Characteristics of inflammatory reactions in the tumor microenvironment of head and neck squamous cell carcinoma
by: V. A. Bychkov, et al.
Published: (2019-01-01)

HEAD AND NECK SQUAMOUS CELL CARCINOMA DEPENDING ON THE MORPHOLOGICAL CHARACTERISTICS OF THE PRIMARY TUMOR
by: V. A. Bychkov, et al.
Published: (2017-06-01)